Unions blame ‘greed’ by healthcare providers, state officials say pricey weight-loss meds and increasing demand for care are ...

The first time around, 59-year-old James Brown lost a stone and a half when he took medication that aids weight loss. This ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Now, drinkers are motioning for a cocktail reformation — specifically, smaller aperitifs suitable for shrinking stomachs and the health-conscious in the post-Ozempic world. “There was a ...

Despite its popularity, Ozempic often leads to temporary weight loss, carries serious side effects, and most users regain ...

The patent on weight loss injection semaglutide is due to expire in 2031, which will let other companies make cut-price ...

GoodRx ran a 12-month survey to better understand the dynamics that shape prescription medication fills and consumer behavior ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...